Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    August 2019
  1. SMITH C, Malek N, Grosset K, Cullen B, et al
    Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    J Neurol Neurosurg Psychiatry. 2019 Aug 23. pii: jnnp-2019-321111.
    PubMed     Text format     Abstract available


  2. MILOSEVIC L, Kalia SK, Hodaie M, Lozano A, et al
    Subthalamic suppression defines therapeutic threshold of deep brain stimulation in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-321140.
    PubMed     Text format     Abstract available


  3. BARGIOTAS P, Debove I, Bargiotas I, Lachenmayer ML, et al
    Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
    J Neurol Neurosurg Psychiatry. 2019 Aug 17. pii: jnnp-2019-320858.
    PubMed     Text format     Abstract available


    June 2019
  4. AVENALI M, Toffoli M, Mullin S, McNeil A, et al
    Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
    J Neurol Neurosurg Psychiatry. 2019 Jun 20. pii: jnnp-2019-320394.
    PubMed     Text format     Abstract available


  5. BARRETT MJ, Sperling SA, Blair JC, Freeman CS, et al
    Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2019 Jun 7. pii: jnnp-2019-320450.
    PubMed     Text format     Abstract available


    May 2019
  6. RICARDO Y, Pavon N, Alvarez L, Casabona E, et al
    Long-term effect of unilateral subthalamotomy for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 May 13. pii: jnnp-2019-320523.
    PubMed     Text format    


  7. PASQUINI J, Durcan R, Wiblin L, Gersel Stokholm M, et al
    Clinical implications of early caudate dysfunction in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 May 11. pii: jnnp-2018-320157.
    PubMed     Text format     Abstract available


    April 2019
  8. CHIVERS SEYMOUR K, Pickering R, Rochester L, Roberts HC, et al
    Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson's.
    J Neurol Neurosurg Psychiatry. 2019 Apr 3. pii: jnnp-2018-319448.
    PubMed     Text format     Abstract available


    March 2019
  9. JABBARI E, Woodside J, Guo T, Magdalinou NK, et al
    Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    J Neurol Neurosurg Psychiatry. 2019 Mar 13. pii: jnnp-2018-320151.
    PubMed     Text format     Abstract available


    February 2019
  10. BARBOSA PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, et al
    The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Feb 1. pii: jnnp-2018-319891.
    PubMed     Text format    


    January 2019
  11. LOW A, Foo H, Yong TT, Tan LCS, et al
    Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Jan 25. pii: jnnp-2018-319592.
    PubMed     Text format     Abstract available


  12. SHEPARD MD, Perepezko K, Broen MPG, Hinkle JT, et al
    Suicide in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2019 Jan 19. pii: jnnp-2018-319815.
    PubMed     Text format     Abstract available


    December 2018
  13. LAWTON M, Ben-Shlomo Y, May MT, Baig F, et al
    Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.
    J Neurol Neurosurg Psychiatry. 2018;89:1279-1287.
    PubMed     Text format     Abstract available


    November 2018
  14. ORTEGA RA, Groves M, Mirelman A, Alcalay RN, et al
    Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2018 Nov 8. pii: jnnp-2018-319364.
    PubMed     Text format    


    October 2018
  15. MARTINEZ-CASTRILLO JC
    Impulse control disorders in Parkinson's disease: a hard-turning point.
    J Neurol Neurosurg Psychiatry. 2018 Oct 25. pii: jnnp-2018-319375.
    PubMed     Text format    


  16. LEE JY, Jeon B, Koh SB, Yoon WT, et al
    Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    J Neurol Neurosurg Psychiatry. 2018 Oct 25. pii: jnnp-2018-318942.
    PubMed     Text format     Abstract available


  17. WOJTALA J, Heber IA, Neuser P, Heller J, et al
    Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    J Neurol Neurosurg Psychiatry. 2018 Oct 8. pii: jnnp-2018-319008.
    PubMed     Text format     Abstract available


    September 2018
  18. LERCHE S, Wurster I, Roben B, Machetanz G, et al
    Parkinson's disease: evolution of cognitive impairment and CSF Abeta1-42 profiles in a prospective longitudinal study.
    J Neurol Neurosurg Psychiatry. 2018 Sep 25. pii: jnnp-2018-318956.
    PubMed     Text format     Abstract available


    August 2018
  19. SAWADA H, Oeda T, Kohsaka M, Umemura A, et al
    Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318107.
    PubMed     Text format     Abstract available


  20. HUGHES KC, Gao X, Baker JM, Stephen C, et al
    Non-motor features of Parkinson's disease in a nested case-control study of US men.
    J Neurol Neurosurg Psychiatry. 2018 Aug 3. pii: jnnp-2018-318275.
    PubMed     Text format     Abstract available


    July 2018
  21. VILAS D, Gelpi E, Aldecoa I, Grau O, et al
    Lack of central and peripheral nervous system synuclein pathology in R1441G LRRK2-associated Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318473.
    PubMed     Text format    


    April 2018
  22. HUMPHRIES MD, Obeso JA, Dreyer JK
    Insights into Parkinson's disease from computational models of the basal ganglia.
    J Neurol Neurosurg Psychiatry. 2018 Apr 17. pii: jnnp-2017-315922.
    PubMed     Text format     Abstract available


    March 2018
  23. WISSEL BD, Dwivedi AK, Merola A, Chin D, et al
    Functional neurological disorders in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317378.
    PubMed     Text format     Abstract available


  24. HALLETT M
    Patients with Parkinson disease are prone to functional neurological disorders.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317684.
    PubMed     Text format    


  25. RADDER DLM, Nonnekes J, Bloem BR
    Intensive inpatient rehabilitation for persons with Parkinson's disease: last resort or pre-emptive strike?
    J Neurol Neurosurg Psychiatry. 2018 Mar 13. pii: jnnp-2017-317812.
    PubMed     Text format    


    February 2018
  26. ABBES M, Lhommee E, Thobois S, Klinger H, et al
    Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.
    J Neurol Neurosurg Psychiatry. 2018 Feb 7. pii: jnnp-2017-316373.
    PubMed     Text format     Abstract available


    January 2018
  27. BLOMSTEDT P, Stenmark Persson R, Hariz GM, Linder J, et al
    Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
    J Neurol Neurosurg Psychiatry. 2018 Jan 31. pii: jnnp-2017-317219.
    PubMed     Text format     Abstract available


  28. MALEK N, Weil RS, Bresner C, Lawton MA, et al
    Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 29. pii: jnnp-2017-317348.
    PubMed     Text format     Abstract available


  29. BOT M, Schuurman PR, Odekerken VJJ, Verhagen R, et al
    Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2018 Jan 20. pii: jnnp-2017-316907.
    PubMed     Text format     Abstract available


  30. FERRAZZOLI D, Ortelli P, Zivi I, Cian V, et al
    Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316437.
    PubMed     Text format     Abstract available


    December 2017
  31. RODRIGUEZ-ROJAS R, Carballo-Barreda M, Alvarez L, Guridi J, et al
    Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241.
    PubMed     Text format     Abstract available


    November 2017
  32. BARBOSA PM, Grippe T, Lees AJ, O'Sullivan S, et al
    Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.
    J Neurol Neurosurg Psychiatry. 2017 Nov 24. pii: jnnp-2017-317298.
    PubMed     Text format    


    October 2017
  33. RICCIARDI L, Lambert C, Micco R, Morgante F, et al
    Can we predict development of impulsive-compulsive behaviours in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2017 Oct 27. pii: jnnp-2017-317007.
    PubMed     Text format     Abstract available


  34. FANTINI ML, Figorilli M, Arnulf I, Zibetti M, et al
    Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.
    J Neurol Neurosurg Psychiatry. 2017 Oct 24. pii: jnnp-2017-316576.
    PubMed     Text format     Abstract available


  35. WARREN N, O'Gorman C, Lehn A, Siskind D, et al
    Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-315985.
    PubMed     Text format     Abstract available


  36. SIMUNI T, Caspell-Garcia C, Coffey CS, Weintraub D, et al
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
    J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316213.
    PubMed     Text format     Abstract available


    September 2017
  37. YE BS, Jeon S, Yoon S, Kang SW, et al
    Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 26. pii: jnnp-2017-316075.
    PubMed     Text format     Abstract available


  38. CHUNG SJ, Yoo HS, Moon H, Oh JS, et al
    Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    J Neurol Neurosurg Psychiatry. 2017 Sep 14. pii: jnnp-2017-315873.
    PubMed     Text format     Abstract available


  39. JOLING M, van den Heuvel OA, Berendse HW, Booij J, et al
    Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 12. pii: jnnp-2017-316193.
    PubMed     Text format     Abstract available


  40. THOMPSON JA, Tekriwal A, Felsen G, Ozturk M, et al
    Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2017 Sep 2. pii: jnnp-2017-316115.
    PubMed     Text format     Abstract available


    August 2017
  41. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
    Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2017 Aug 28. pii: jnnp-2017-316136.
    PubMed     Text format     Abstract available


  42. ROSSI PJ, Shute JB, Opri E, Molina R, et al
    Impulsivity in Parkinson's disease is associated with altered subthalamic but not globus pallidus internus activity.
    J Neurol Neurosurg Psychiatry. 2017 Aug 19. pii: jnnp-2016-315325.
    PubMed     Text format     Abstract available


    July 2017
  43. CILIA R, Asselta R, Cereda E, Benfante R, et al
    Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-316235.
    PubMed     Text format    


    June 2017
  44. VAN DER KOLK NM, de Vries NM, Penko AL, van der Vlugt M, et al
    A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315728.
    PubMed     Text format    


  45. AARSLAND D, Rajkumar AP, Hye A
    Novel evidence associates higher plasma alpha-synuclein levels and cognitive impairment in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315821.
    PubMed     Text format    


  46. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Text format     Abstract available


    May 2017
  47. AMARA AW, Chahine LM, Caspell-Garcia C, Long JD, et al
    Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 29. pii: jnnp-2016-315023.
    PubMed     Text format     Abstract available


  48. LIN CH, Yang SY, Horng HE, Yang CC, et al
    Plasma alpha-synuclein predicts cognitive decline in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 26. pii: jnnp-2016-314857.
    PubMed     Text format     Abstract available


    April 2017
  49. FFYTCHE DH, Pereira JB, Ballard C, Chaudhuri KR, et al
    Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    J Neurol Neurosurg Psychiatry. 2017;88:325-331.
    PubMed     Text format     Abstract available


  50. ANTONINI A, Barone P, Bonuccelli U, Annoni K, et al
    ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017;88:317-324.
    PubMed     Text format     Abstract available


  51. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Text format     Abstract available


    March 2017
  52. LAWSON RA, Yarnall AJ, Duncan GW, Breen DP, et al
    Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-315099.
    PubMed     Text format     Abstract available


  53. HO AL, Ali R, Connolly ID, Henderson JM, et al
    Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-314500.
    PubMed     Text format     Abstract available


  54. NOYCE AJ, Schrag A, Masters JM, Bestwick JP, et al
    Subtle motor disturbances in PREDICT-PD participants.
    J Neurol Neurosurg Psychiatry. 2017;88:212-217.
    PubMed     Text format     Abstract available


    December 2016
  55. TEKRIWAL A, Kern DS, Tsai J, Ince NF, et al
    REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Dec 13. pii: jnnp-2016-314471.
    PubMed     Text format     Abstract available


    November 2016
  56. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Text format     Abstract available


  57. COLLETT J, Franssen M, Meaney A, Wade D, et al
    Phase II randomised controlled trial of a 6-month self-managed community exercise programme for people with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Nov 11. pii: jnnp-2016-314508.
    PubMed     Text format     Abstract available


    October 2016
  58. DE PABLO-FERNANDEZ E, Breen DP, Bouloux PM, Barker RA, et al
    Neuroendocrine abnormalities in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Oct 31. pii: jnnp-2016-314601.
    PubMed     Text format     Abstract available


    September 2016
  59. SWALLOW DM, Lawton MA, Grosset KA, Malek N, et al
    Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313642.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: